·   Log in

Archive for March 12th, 2010

Methylnaltrexone (Relistor) pills to treat constipation to go on crucial phase of clinical studies, says Progenics

Friday, March 12, 2010 19:38

Methylnaltrexone, an oral tablet for opioid-induced constipation (OIC) by Progenics, will soon undergo late stage clinical studies.

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments
Tagged with: ,

Bayer looks to double workforce in India; targets to be among top 10 by 2015

Friday, March 12, 2010 19:04

Bayer Schering Pharma AG, Germany's largest pharmaceutical company is planning to double its sales force in India as part of its strategy to make Asia an important market through making huge investments in the region, reports said.

This was posted under category: Featured, Industry  |  Read Full Story  |  0 Comments
Tagged with: ,

Oral contraceptive pills could help women live longer; cut heart disease, cancer risks: Study

Friday, March 12, 2010 15:18

Contraceptive pills used by women for birth-control could help them lead a longer life with lesser risk of major life-threatening conditions like heart disease and cancer, says a new study.

This was posted under category: Consumer, health  |  Read Full Story  |  0 Comments
Tagged with: ,

Stem cell-based vaccine against brain cancer improves survival:ImmunoCellular

Friday, March 12, 2010 12:31

A dendritic cell-based vaccination with cancer stem cells developed by ImmunoCellular has been found improving the survival rate of brain cancer -glioblastoma - patients.

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments

Bayer’s cipro inhaler to treat cystic fibrosis may get priority review in US

Friday, March 12, 2010 11:00

Ciprofloxacin dry powder inhaler to treat cystic fibrosis caused by Pseudomonas aeruginosa has been given Orphan Drug designation in US, announced Bayer Healthcare.

This was posted under category: health  |  Read Full Story  |  0 Comments